Shares of Corbus Pharmaceuticals Holdings Inc. CRBP surged 13.11% to $1.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.65% to 11,709.59 and Dow Jones Industrial Average DJIA falling 1.08% to 29,080.17. Corbus Pharmaceuticals Holdings Inc. closed $8.40 below its 52-week high ($9.78), which the company achieved on August 31st.
The stock outperformed some of its competitors Thursday, as Fate Therapeutics Inc. FATE fell 2.62% to $51.98, Vanda Pharmaceuticals Inc. VNDA fell 1.03% to $12.95, and Viking Therapeutics Inc. VKTX fell 0.16% to $6.09. Trading volume (12.9 M) eclipsed its 50-day average volume of 6.0 M.